MICROBIOME THERAPEUTIC INNOVATION GROUP

Microbiome Therapeutics Innovation Group

MTIG is dedicated to enhancing the regulatory, investment, and commercial environment to accelerate microbiome therapeutic drug product development. MTIG is dedicated to enhancing the regulatory, investment, and commercial environment to accelerate microbiome therapeutic drug product development.
824927284
EIN
2017
Founded
WASHINGTON, DC 20004
Address
microbiometig.org
Web
MTIG_News
Twitter (3801)
MTIGNews
Facebook (11694)

News

Poslední diskuze

Nearby

Contact
MICROBIOME THERAPEUTIC INNOVATION GROUP logo
MICROBIOME THERAPEUTIC INNOVATION GROUP
+ Follow
4.5
Reviews
WASHINGTON
Place
About the organization

- S41 -

Leading the research and developmentof FDAapproved microbiome therapeuticsand microbiomebased products Mission About the Microbiome Inquire about Membership Member Companies TheMicrobiomeTherapeuticsInnovation Group MTIG is an independent 501c6 coalition of companies leading the research and development of FDAapproved microbiome therapeutics and microbiomebased products to address unmet medical needs improve clinical outcomes and reduce health care costs. Inquire about Membership All pharmaceutical and biotechnology companies pursuing regulatory approvals for microbiome therapeutics and microbiomebased products are eligible for consideration of membership in MTIG. Learn More . .

Promotion of Business (Chambers of Commerce)
23 Vacancy More Detail